Interstitial fluid responds quickly to sugar molecules
This article was originally published in Clinica
Executive Summary
Sugar molecules move quickly from blood into the fluid between cells, researchers at US company SpectRx have shown, confirming the potential value of interstitial fluid for glucose monitoring in diabetics. Norcross, Georgia-based SpectRx is one of a growing number of device manufacturers hoping to develop non-invasive glucose monitors based on the technique.